IMR Press / FBL / Volume 13 / Issue 9 / DOI: 10.2741/2951

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
The p38 MAPK stress pathway as a tumor suppressor or more?
Show Less
1 Department of Pharmacology and Toxicology, Zablocki Department of Veterans Affairs Medical Center, Medical College of Wisconsin, WI 53226

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(9), 3581–3593; https://doi.org/10.2741/2951
Published: 1 May 2008
Abstract

p38 mitogen-activated protein kinases (p38 MAPKs) are a group of serine/threonine protein kinases that together with ERK (extracellular signal-regulated kinases) and JNK (c-Jun N-terminal kinases) MAPKs act to convert different extracellular signals into specific cellular responses through interacting with and phosphorylating downstream targets. In contrast to the mitogenic ERK pathway, mammalian p38 MAPK family proteins (alpha, beta, gamma, and delta), with and without JNK participation, predominantly regulate inflammatory and stress response. Recent emerging evidence suggests that the p38 stress MAPK pathway may function as a tumor suppressor through regulating Ras-dependent and - independent proliferation, transformation, invasion and cell death by isoform-specific mechanisms. A selective activation of a stress pathway to block tumorigenesis may be a novel strategy to control human malignancies.

Share
Back to top